Navigation Links
Van Andel Institute Research Symposium Showcases Latest Developments In Parkinson's Research
Date:9/20/2012

GRAND RAPIDS, Mich., Sept. 20, 2012 /PRNewswire/ -- Van Andel Institute (VAI) hosts a scientific symposium September 19-20 that gathers some of the world's most noted experts in Parkinson's disease and reinforces the region's growing reputation in the field of Parkinson's research.

Grand Challenges in Parkinson's Disease features experts from a dozen nations including Australia, Malaysia and Sweden. The purpose of the event is to showcase the latest research in the field and to honor Andrew B. Singleton, Ph.D., of the National Institutes of Health (NIH) with the first Jay Van Andel Award for Outstanding Achievement in Parkinson's Disease Research.

"This is truly a gathering of some of the world's greatest minds in Parkinson's disease research," said chief event organizer Patrik Brundin, M.D., Ph.D., Chair of the Jay Van Andel Translational Parkinson's Disease Research Laboratory and Director of Van Andel Institute's Center for Neurodegenerative Science. "We will be sharing the results of recent and ongoing research that will become the building blocks for therapies that may be commonplace a decade from now."

The event features keynote addresses by noted Parkinson's experts Ted Dawson, M.D., Ph.D., of The Johns Hopkins University, who will speak on the topic of Looking Forward to Tomorrow's Therapies for Parkinson's Disease, and Roger Barker, Ph.D., of University of Cambridge, who will speak on Matching Therapies to Patients: The Complexities of Disease Heterogeneity in Parkinson's Disease.

Dr. Andrew Singleton is best known for his work aimed at understanding the genetic causes of Parkinson's disease – work that is opening entire new fields of research.

His first well-known work described the discovery of a duplication and triplication of the alpha-synuclein gene that causes a severe, early-onset form of Parkinson's disease. Scientists already knew that a few extremely rare mutant forms of the protein were bad, but Dr. Singleton showed that too much of the normal protein also has ramifications.

One year later he led the group that was the first to identify mutations in the LRRK2 gene as a cause of familial Parkinson's disease. Occasionally new mutations arise in this gene, which can explain some of the cases of the more common, sporadic Parkinson's disease.

For more information, please visit www.vai.org


'/>"/>
SOURCE Van Andel Institute
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Van Andel Research Institute Study Provides New Details of Fundamental Cellular Process
2. Van Andel Institute Partners with UNCF to Recruit Students to Biomedical Research Careers
3. Candelis and Microsoft Team Up to Empower Patients
4. Genetics Policy Institute (GPI) Collaborates on Second Midwest Conference on Stem Cell Biology and Therapy, Oct. 5-7 at Oakland University
5. California Healthcare Institute Issues Statement on Supreme Court Ruling on the Affordable Care Act
6. Scripps Research Institute scientists find easier way to make new drug compounds
7. Soligenix Announces Collaboration with Infectious Disease Research Institute to Develop Thermostabilized Biodefense Vaccines Utilizing Novel Adjuvants
8. West Wireless Health Institute Applauds House Passage of Bill to Streamline FDA Medical Device Approval Process, Expedite Mobile Medical App Guidance
9. New Competitive Arena Emerges for Pharmaceutical Companies in Healthcares Changing Payment Landscape, Finds PwC Health Research Institute Study
10. Profil Institute Reports Record Growth in Number of Clinical Trials in the Pipeline
11. The Italian Institute of Prophylaxis against Animal Diseases (IZS) to test effectiveness of BeesFree Inc.s Technology in Combating Colony Collapse Disorder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ca (PRWEB) , ... October 12, 2017 , ... ... the Surgical Wound Market with the addition of its newest module, US Hemostats ... $1.2B market for thrombin hemostats, absorbable hemostats, fibrin sealants, synthetic sealants and biologic ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... the first-ever genomics analysis platform specifically designed for life science researchers to ... of pioneering researcher Rosalind Franklin, who made a major contribution to the ...
(Date:10/11/2017)... YORBA LINDA, CA (PRWEB) , ... October 11, ... ... adapted to upregulate any gene in its endogenous context, enabling overexpression experiments and ... activation (CRISPRa) system with small RNA guides is transformative for performing systematic gain-of-function ...
(Date:10/11/2017)... ... October 11, 2017 , ... ComplianceOnline’s Medical Device Summit is ... and 8th June 2018 in San Francisco, CA. The Summit brings together current and ... distinguished CEOs, board directors and government officials from around the world to address key ...
Breaking Biology Technology:
(Date:6/30/2017)... June 30, 2017 Today, American Trucking ... supplier of face and eye tracking software, became ... provider program. "Artificial intelligence and ... to monitor a driver,s attentiveness levels while on ... able to detect fatigue and prevent potential accidents, ...
(Date:5/16/2017)... , May 16, 2017  Veratad Technologies, LLC ( ... online age and identity verification solutions, announced today they ... Conference 2017, May 15 thru May 17, 2017, in ... and International Trade Center. Identity impacts ... and in today,s quickly evolving digital world, defining identity ...
(Date:4/19/2017)... ALBANY, New York , April 19, 2017 /PRNewswire/ ... highly competitive, as its vendor landscape is marked by ... in the market is however held by five major ... and Safran. Together these companies accounted for nearly 61% ... majority of the leading companies in the global military ...
Breaking Biology News(10 mins):